Transactions
19
Insider / NEOGENOMICS INC
Olivo Alicia C
EVP, GC & Business Development at NEOGENOMICS INC
- Company
- NEOGENOMICS INC
- Ticker
- NEO
- First filing on record
- October 20, 2025
- Latest trade on record
- September 1, 2026
- SEC filings
- EDGAR ↗
Olivo Alicia C, EVP, GC & Business Development at NEOGENOMICS INC, has disclosed 19 transactions in NEO since October 20, 2025: 0 purchases (0 open-market buys) and 8 sales, worth about $390K at the reported prices. The latest was filed September 3, 2026, 2 days after the trade.
Open-market buys
0
Sales
8
Avg. disclosure lag
2.4d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Olivo Alicia C made no purchases and 7 sales worth $251K, plus 11 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Olivo Alicia C has traded 1 stock on record; the largest by dollars is NEO.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 8 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 9 | 144,268 | $90K |
| F | Shares withheld for tax | 6 | 33,056 | — |
| A | Grant or award | 2 | 236,817 | — |
| S | Open-market sale | 2 | 25,834 | $300K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 15 | 0 | 6 · $0 |
| 2025 | 4 | 0 | 2 · $300K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| NEO | Sell F | September 1, 2026 | September 3, 2026 | 2d | 2,692 | — | — | Form 4 ↗ | ||
| NEO | Option / conversion M | May 11, 2026 | May 13, 2026 | 2d | 3,944 | — | — | derivative | Form 4 ↗ | |
| NEO | Sell F | May 11, 2026 | May 13, 2026 | 2d | 2,559 | — | — | Form 4 ↗ | ||
| NEO | Option / conversion M | May 11, 2026 | May 13, 2026 | 2d | 3,944 | — | — | Form 4 ↗ | ||
| NEO | Sell F | May 1, 2026 | May 5, 2026 | 4d | 1,042 | — | — | Form 4 ↗ | ||
| NEO | Other A | March 1, 2026 | March 3, 2026 | 2d | 89,013 | — | — | derivative | Form 4 ↗ | |
| NEO | Other A | March 1, 2026 | March 3, 2026 | 2d | 147,804 | — | — | derivative | Form 4 ↗ | |
| NEO | Option / conversion M | February 23, 2026 | February 24, 2026 | 1d | 8,443 | — | — | derivative | Form 4 ↗ | |
| NEO | Option / conversion M | February 21, 2026 | February 24, 2026 | 3d | 21,079 | — | — | derivative | Form 4 ↗ | |
| NEO | Sell F | February 23, 2026 | February 24, 2026 | 1d | 3,323 | — | — | Form 4 ↗ | ||
| NEO | Option / conversion M | February 23, 2026 | February 24, 2026 | 1d | 8,443 | — | — | Form 4 ↗ | ||
| NEO | Sell F | February 21, 2026 | February 24, 2026 | 3d | 8,295 | — | — | Form 4 ↗ | ||
| NEO | Option / conversion M | February 21, 2026 | February 24, 2026 | 3d | 21,079 | — | — | Form 4 ↗ | ||
| NEO | Sell F | January 13, 2026 | January 15, 2026 | 2d | 15,145 | — | — | Form 4 ↗ | ||
| NEO | Option / conversion M | January 13, 2026 | January 15, 2026 | 2d | 59,382 | — | — | Form 4 ↗ | ||
| NEO | Option / conversion M | November 25, 2025 | November 28, 2025 | 3d | 8,977 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| NEO | Sell S | November 25, 2025 | November 28, 2025 | 3d | 20,916 | $12 | $251K | 10b5-1 plan | Form 4 ↗ | |
| NEO | Option / conversion M | November 25, 2025 | November 28, 2025 | 3d | 8,977 | $10 | $90K | 10b5-1 plan | Form 4 ↗ | |
| NEO | Sell S | October 16, 2025 | October 20, 2025 | 4d | 4,918 | $10 | $49K | 10b5-1 plan | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| September 3, 2026 | Form 4 | 0001628280-26-060499 | 1 | published | EDGAR ↗ |
| May 13, 2026 | Form 4 | 0001628280-26-034620 | 3 | published | EDGAR ↗ |
| May 5, 2026 | Form 4 | 0001628280-26-030621 | 1 | published | EDGAR ↗ |
| March 3, 2026 | Form 4 | 0001628280-26-014149 | 2 | published | EDGAR ↗ |
| February 24, 2026 | Form 4 | 0001628280-26-011097 | 6 | published | EDGAR ↗ |
| January 15, 2026 | Form 4 | 0001628280-26-002198 | 2 | published | EDGAR ↗ |
| November 28, 2025 | Form 4 | 0001628280-25-054270 | 3 | published | EDGAR ↗ |
| October 20, 2025 | Form 4 | 0001628280-25-045529 | 1 | published | EDGAR ↗ |
Other insiders at NEOGENOMICS INC
- Stone Warren Pres & Chief Operating Officer 27 rows
- Aunan Greg D Chief Accounting Officer 10 rows
- Sherman Jeffrey Scott Chief Financial Officer 7 rows
- Kenny John P. Director 6 rows
- TETRAULT LYNN A. Director 6 rows
- Zook Anthony P. Chief Executive Officer 5 rows
- Green Marjorie C Director 4 rows
- Gunn Neil Director 4 rows
- KANOVSKY STEPHEN M Director 4 rows
- Kelly Michael Aaron Director 4 rows
Everyone on file, with contracts and lobbying under the company's name: NEOGENOMICS INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 8 | 19 | October 20, 2025 | September 3, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.